Inhibits PGE2 formation
Beneficial effect in cardiovascular diseases and inflammation. Inhibits PGE2 formation from arachidonic acid in 3T3 fibroblats.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
| Alternative Name |
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic acid (20:5, n-3), Icosapent |
|---|---|
| Appearance |
Colorless oil. |
| CAS |
10417-94-4 |
| Couple Target |
Prostaglandin E2 |
| Couple Type |
Inhibitor |
| Formula |
C20H30O2 |
| MW |
302.5 |
| Purity |
≥98% (TLC) |
| Solubility |
Soluble in 100% ethanol. |
Handling & Storage
| Use/Stability |
As indicated on product label or CoA when stored as recommended. Stable for at least 1 year after receipt when stored, as supplied, at -20°C. After opening, store under an inert atmosphere (e.g. N2 or argon) at -80°C. Stock solutions are stable for up to 2 months at -80°C under an inert atmosphere. |
|---|---|
| Handling |
Protect from air. |
| Long Term Storage |
-20°C |
| Shipping |
Dry Ice |
| Regulatory Status |
RUO – Research Use Only |
|---|
- Differential effects of n-6 and n-3 polyunsaturated fatty acids on cell growth and early gene expression in Swiss 3T3 fibroblasts: U. Danesch, et al.; J. Cell. Physiol. 168, 618 (1996), Abstract
- Eicosapentaenoic acid: its relevance in atherosclerosis and coronary artery disease: J. Mehta, et al.; Am. J. Cardiol. 59, 155 (1987), Abstract
- Eicosapentaenoic acid as a modulator of inflammation. Effect on prostaglandin and leukotriene synthesis: T. Terano, et al.; Biochem. Pharmacol. 35, 779 (1986), Abstract
- Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function: T.H. Lee, et al.; N. Engl. J. Med. 312, 1217 (1985), Abstract
Related Products
| CAS | 38966-21-1 |
|---|---|
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-(3H)-furanone |
|---|---|
| CAS | 7770-78-7 |
| Couple Type | Inhibitor |
| Purity | ≥97% (HPLC) |
| Alternative Name | (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]-3-[[4-(β-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-2(3H)-furanone |
|---|---|
| CAS | 20362-31-6 |
| Couple Type | Inhibitor |
| Purity | ≥95% (HPLC) |
| Alternative Name | EGCG, (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate) |
|---|---|
| CAS | 989-51-5 |
| Couple Type | Inhibitor |
| Purity | ≥98% (HPLC) |
Last modified: May 29, 2024
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form
Lab Essentials
AMPIVIEW® RNA probes
Enabling Your Projects
GMP Services
Bulk Solutions
Research Travel Grant
Have You Published Using an Enzo Product?